The company's Finance Receivables and Pharmaceutical Development Services segments generate its maximum revenue, and it also provides non-discretionary investment advisory services to institutional clients. SWK believes its financing structures achieve an optimal partnership for companies, institutions, and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes.